0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Coronavirus Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-25G1930
Home | Market Reports | Science
Global Coronavirus Diagnostics Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Coronavirus Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25G1930
Report
November 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Coronavirus Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Coronavirus Diagnostics - Market

Coronavirus Diagnostics - Market

The global market for Coronavirus Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronavirus Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Coronavirus Diagnostics by region & country, by Type, and by Application.
The Coronavirus Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Diagnostics.
Market Segmentation

Scope of Coronavirus Diagnostics - Market Report

Report Metric Details
Report Name Coronavirus Diagnostics - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospital
  • Public Health Laboratory
  • Internal Medicine Laboratory
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Diagnostics, Abbott, Bio-Rad Laboratories, Beckman Coulter, Becton,Dickinson and Company, Lonza, bioMerieux, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Coronavirus Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Coronavirus Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Coronavirus Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Coronavirus Diagnostics - Market report?

Ans: The main players in the Coronavirus Diagnostics - Market are Roche Diagnostics, Abbott, Bio-Rad Laboratories, Beckman Coulter, Becton,Dickinson and Company, Lonza, bioMerieux, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics

What are the Application segmentation covered in the Coronavirus Diagnostics - Market report?

Ans: The Applications covered in the Coronavirus Diagnostics - Market report are Hospital, Public Health Laboratory, Internal Medicine Laboratory, Other

What are the Type segmentation covered in the Coronavirus Diagnostics - Market report?

Ans: The Types covered in the Coronavirus Diagnostics - Market report are Laboratory Instrument Testing, Kit Test

Recommended Reports

COVID-19 Diagnostics

Infectious Disease Testing

COVID-19 Therapeutics

1 Market Overview
1.1 Coronavirus Diagnostics Product Introduction
1.2 Global Coronavirus Diagnostics Market Size Forecast
1.3 Coronavirus Diagnostics Market Trends & Drivers
1.3.1 Coronavirus Diagnostics Industry Trends
1.3.2 Coronavirus Diagnostics Market Drivers & Opportunity
1.3.3 Coronavirus Diagnostics Market Challenges
1.3.4 Coronavirus Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Coronavirus Diagnostics Players Revenue Ranking (2023)
2.2 Global Coronavirus Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Coronavirus Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Coronavirus Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Coronavirus Diagnostics
2.6 Coronavirus Diagnostics Market Competitive Analysis
2.6.1 Coronavirus Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Coronavirus Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Laboratory Instrument Testing
3.1.2 Kit Test
3.2 Global Coronavirus Diagnostics Sales Value by Type
3.2.1 Global Coronavirus Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Coronavirus Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Coronavirus Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Public Health Laboratory
4.1.3 Internal Medicine Laboratory
4.1.4 Other
4.2 Global Coronavirus Diagnostics Sales Value by Application
4.2.1 Global Coronavirus Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Coronavirus Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Coronavirus Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Coronavirus Diagnostics Sales Value by Region
5.1.1 Global Coronavirus Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Coronavirus Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Coronavirus Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Coronavirus Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Coronavirus Diagnostics Sales Value, 2019-2030
5.2.2 North America Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Coronavirus Diagnostics Sales Value, 2019-2030
5.3.2 Europe Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Coronavirus Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Coronavirus Diagnostics Sales Value, 2019-2030
5.5.2 South America Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Coronavirus Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Coronavirus Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Coronavirus Diagnostics Sales Value
6.3 United States
6.3.1 United States Coronavirus Diagnostics Sales Value, 2019-2030
6.3.2 United States Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Coronavirus Diagnostics Sales Value, 2019-2030
6.4.2 Europe Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Coronavirus Diagnostics Sales Value, 2019-2030
6.5.2 China Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Coronavirus Diagnostics Sales Value, 2019-2030
6.6.2 Japan Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Coronavirus Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Coronavirus Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Coronavirus Diagnostics Sales Value, 2019-2030
6.9.2 India Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Coronavirus Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Profile
7.1.2 Roche Diagnostics Main Business
7.1.3 Roche Diagnostics Coronavirus Diagnostics Products, Services and Solutions
7.1.4 Roche Diagnostics Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Diagnostics Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Coronavirus Diagnostics Products, Services and Solutions
7.2.4 Abbott Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Profile
7.3.2 Bio-Rad Laboratories Main Business
7.3.3 Bio-Rad Laboratories Coronavirus Diagnostics Products, Services and Solutions
7.3.4 Bio-Rad Laboratories Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Beckman Coulter Recent Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Profile
7.4.2 Beckman Coulter Main Business
7.4.3 Beckman Coulter Coronavirus Diagnostics Products, Services and Solutions
7.4.4 Beckman Coulter Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Beckman Coulter Recent Developments
7.5 Becton,Dickinson and Company
7.5.1 Becton,Dickinson and Company Profile
7.5.2 Becton,Dickinson and Company Main Business
7.5.3 Becton,Dickinson and Company Coronavirus Diagnostics Products, Services and Solutions
7.5.4 Becton,Dickinson and Company Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Becton,Dickinson and Company Recent Developments
7.6 Lonza
7.6.1 Lonza Profile
7.6.2 Lonza Main Business
7.6.3 Lonza Coronavirus Diagnostics Products, Services and Solutions
7.6.4 Lonza Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Lonza Recent Developments
7.7 bioMerieux
7.7.1 bioMerieux Profile
7.7.2 bioMerieux Main Business
7.7.3 bioMerieux Coronavirus Diagnostics Products, Services and Solutions
7.7.4 bioMerieux Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 bioMerieux Recent Developments
7.8 Hologic
7.8.1 Hologic Profile
7.8.2 Hologic Main Business
7.8.3 Hologic Coronavirus Diagnostics Products, Services and Solutions
7.8.4 Hologic Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Hologic Recent Developments
7.9 Qiagen
7.9.1 Qiagen Profile
7.9.2 Qiagen Main Business
7.9.3 Qiagen Coronavirus Diagnostics Products, Services and Solutions
7.9.4 Qiagen Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Qiagen Recent Developments
7.10 GSK Biologicals
7.10.1 GSK Biologicals Profile
7.10.2 GSK Biologicals Main Business
7.10.3 GSK Biologicals Coronavirus Diagnostics Products, Services and Solutions
7.10.4 GSK Biologicals Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 GSK Biologicals Recent Developments
7.11 PerkinElmer
7.11.1 PerkinElmer Profile
7.11.2 PerkinElmer Main Business
7.11.3 PerkinElmer Coronavirus Diagnostics Products, Services and Solutions
7.11.4 PerkinElmer Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 PerkinElmer Recent Developments
7.12 Ortho-Clinical Diagnostics
7.12.1 Ortho-Clinical Diagnostics Profile
7.12.2 Ortho-Clinical Diagnostics Main Business
7.12.3 Ortho-Clinical Diagnostics Coronavirus Diagnostics Products, Services and Solutions
7.12.4 Ortho-Clinical Diagnostics Coronavirus Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Ortho-Clinical Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Coronavirus Diagnostics Industrial Chain
8.2 Coronavirus Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Coronavirus Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Coronavirus Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Coronavirus Diagnostics Market Trends
    Table 2. Coronavirus Diagnostics Market Drivers & Opportunity
    Table 3. Coronavirus Diagnostics Market Challenges
    Table 4. Coronavirus Diagnostics Market Restraints
    Table 5. Global Coronavirus Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Coronavirus Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Coronavirus Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Coronavirus Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Coronavirus Diagnostics
    Table 10. Global Coronavirus Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Coronavirus Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Coronavirus Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Coronavirus Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Coronavirus Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Coronavirus Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Coronavirus Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Coronavirus Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Coronavirus Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Coronavirus Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Coronavirus Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Coronavirus Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Coronavirus Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Coronavirus Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Coronavirus Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Coronavirus Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Coronavirus Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Coronavirus Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Coronavirus Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Diagnostics Basic Information List
    Table 32. Roche Diagnostics Description and Business Overview
    Table 33. Roche Diagnostics Coronavirus Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Coronavirus Diagnostics Business of Roche Diagnostics (2019-2024)
    Table 35. Roche Diagnostics Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott Coronavirus Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Coronavirus Diagnostics Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Bio-Rad Laboratories Basic Information List
    Table 42. Bio-Rad Laboratories Description and Business Overview
    Table 43. Bio-Rad Laboratories Coronavirus Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Coronavirus Diagnostics Business of Bio-Rad Laboratories (2019-2024)
    Table 45. Bio-Rad Laboratories Recent Developments
    Table 46. Beckman Coulter Basic Information List
    Table 47. Beckman Coulter Description and Business Overview
    Table 48. Beckman Coulter Coronavirus Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Coronavirus Diagnostics Business of Beckman Coulter (2019-2024)
    Table 50. Beckman Coulter Recent Developments
    Table 51. Becton,Dickinson and Company Basic Information List
    Table 52. Becton,Dickinson and Company Description and Business Overview
    Table 53. Becton,Dickinson and Company Coronavirus Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Coronavirus Diagnostics Business of Becton,Dickinson and Company (2019-2024)
    Table 55. Becton,Dickinson and Company Recent Developments
    Table 56. Lonza Basic Information List
    Table 57. Lonza Description and Business Overview
    Table 58. Lonza Coronavirus Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Coronavirus Diagnostics Business of Lonza (2019-2024)
    Table 60. Lonza Recent Developments
    Table 61. bioMerieux Basic Information List
    Table 62. bioMerieux Description and Business Overview
    Table 63. bioMerieux Coronavirus Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Coronavirus Diagnostics Business of bioMerieux (2019-2024)
    Table 65. bioMerieux Recent Developments
    Table 66. Hologic Basic Information List
    Table 67. Hologic Description and Business Overview
    Table 68. Hologic Coronavirus Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Coronavirus Diagnostics Business of Hologic (2019-2024)
    Table 70. Hologic Recent Developments
    Table 71. Qiagen Basic Information List
    Table 72. Qiagen Description and Business Overview
    Table 73. Qiagen Coronavirus Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Coronavirus Diagnostics Business of Qiagen (2019-2024)
    Table 75. Qiagen Recent Developments
    Table 76. GSK Biologicals Basic Information List
    Table 77. GSK Biologicals Description and Business Overview
    Table 78. GSK Biologicals Coronavirus Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Coronavirus Diagnostics Business of GSK Biologicals (2019-2024)
    Table 80. GSK Biologicals Recent Developments
    Table 81. PerkinElmer Basic Information List
    Table 82. PerkinElmer Description and Business Overview
    Table 83. PerkinElmer Coronavirus Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Coronavirus Diagnostics Business of PerkinElmer (2019-2024)
    Table 85. PerkinElmer Recent Developments
    Table 86. Ortho-Clinical Diagnostics Basic Information List
    Table 87. Ortho-Clinical Diagnostics Description and Business Overview
    Table 88. Ortho-Clinical Diagnostics Coronavirus Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Coronavirus Diagnostics Business of Ortho-Clinical Diagnostics (2019-2024)
    Table 90. Ortho-Clinical Diagnostics Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Coronavirus Diagnostics Downstream Customers
    Table 94. Coronavirus Diagnostics Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Coronavirus Diagnostics Product Picture
    Figure 2. Global Coronavirus Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Coronavirus Diagnostics Report Years Considered
    Figure 5. Global Coronavirus Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Coronavirus Diagnostics Revenue in 2023
    Figure 7. Coronavirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Laboratory Instrument Testing Picture
    Figure 9. Kit Test Picture
    Figure 10. Global Coronavirus Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Coronavirus Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Public Health Laboratory
    Figure 14. Product Picture of Internal Medicine Laboratory
    Figure 15. Product Picture of Other
    Figure 16. Global Coronavirus Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Coronavirus Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Coronavirus Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Coronavirus Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Coronavirus Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Coronavirus Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Coronavirus Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Coronavirus Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Coronavirus Diagnostics Industrial Chain
    Figure 51. Coronavirus Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS